ClinicalTrials.Veeva

Menu

Effect of Adaptive Servoventilation on Cardiac Function in Chronic Heart Failure and Cheyne-Stokes Respiration

M

Military Institute od Medicine National Research Institute

Status

Unknown

Conditions

Cheyne-Stokes Respiration
Chronic Heart Failure
Central Sleep Apnea

Treatments

Device: Adaptive servoventilation

Study type

Interventional

Funder types

Other

Identifiers

NCT01212705
BW2126/10

Details and patient eligibility

About

Sleep disordered breathing is common in patients with chronic heart failure. Adaptive servoventilation is a novel method of treatment central sleep apnoea, especially associated with Cheyne-Stokes-respiration. The aim of the study is to investigate effect of adaptive servoventilation on cardiac function, exercise tolerance and quality of life in patients with chronic heart failure.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic heart failure with ejection fraction ≤45%
  • optimal medical treatment for at least 1 month
  • clinical diagnosis of Cheyne-Stokes respiration

Exclusion criteria

  • unstable heart failure
  • stroke
  • transient ischemic attack in last 6 months
  • pacemaker, cardioverter-defibrillator or resynchronization device implanted less than 6 months before study entrance
  • severe chronic obstructive pulmonary disease

Trial design

0 participants in 1 patient group

ASV
Experimental group
Treatment:
Device: Adaptive servoventilation

Trial contacts and locations

1

Loading...

Central trial contact

Anna Kazimierczak; Krystian Krzyzanowski

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems